Free tool
Oncology stocks
We cover 287 companies grouped under the Oncology theme. The median market value in the group is $109.84M. Across the group, the median move over the past trading day is +1.02%. 47% of the 277 with a 200-day average trade above it. Price change over the past year runs from −77.1% to +202.6% across the middle 80 percent of the group, with a median of −6.7%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
287 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +67.40% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +62.22% |
| CGON | CG Oncology, Inc. | $7.00B | Mid cap | +210.58% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +79.61% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +212.13% |
| ERAS | Erasca, Inc. | $6.16B | Mid cap | +1016.98% |
| 000100.KS | Yuhan Corporation | $4.67B | Mid cap | −25.59% |
| 0I3Q.L | Corcept Therapeutics Incorporated | $4.54B | Mid cap | +75.99% |
| RLAY | Relay Therapeutics, Inc. | $4.51B | Mid cap | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $4.48B | Mid cap | +205.89% |
| CELC | Celcuity Inc. | $4.44B | Mid cap | +87.35% |
| TNGX | Tango Therapeutics, Inc. | $4.13B | Mid cap | +264.73% |
| IDYA | IDEAYA Biosciences, Inc. | $4.10B | Mid cap | +71.91% |
| RCUS | Arcus Biosciences, Inc. | $4.02B | Mid cap | +211.03% |
| TLX | Telix Pharmaceuticals Limited | $3.96B | Mid cap | −4.26% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.91B | Mid cap | −12.72% |
| 000105.KS | Yuhan Corporation | $3.88B | Mid cap | −31.05% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +196.22% |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | Mid cap | +637.70% |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% |
| NUVB | Nuvation Bio Inc. | $2.49B | Mid cap | +146.53% |
| URGN | UroGen Pharma Ltd. | $2.27B | Mid cap | +150.59% |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% |
| HCM | HUTCHMED (China) Limited | $2.13B | Mid cap | −23.04% |
| HCM.L | HUTCHMED (China) Limited | $2.12B | Mid cap | −21.24% |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% |
| NVCR | NovoCure Limited | $2.05B | Mid cap | +50.60% |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +14.76% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +800.59% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.89B | Small cap | −44.50% |
| VIR | Vir Biotechnology, Inc. | $1.81B | Small cap | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +27.20% |
| BCAX | Bicara Therapeutics Inc. | $1.63B | Small cap | +117.14% |
| AAPG | Ascentage Pharma Group Internat | $1.57B | Small cap | −61.38% |
| AVBP | ArriVent BioPharma, Inc. | $1.55B | Small cap | +62.02% |
| REPL | Replimune Group, Inc. | $1.49B | Small cap | +187.80% |
| AKTS | Aktis Oncology, Inc. | $1.48B | Small cap | +19.15% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.40B | Small cap | +43.76% |
| DRTS | Alpha Tau Medical Ltd. | $1.36B | Small cap | +357.94% |
| IMTX | Immatics N.V. | $1.26B | Small cap | +76.67% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.24B | Small cap | +217.21% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.16% |
| 0HFQ.L | AnaptysBio, Inc. | $1.20B | Small cap | +183.92% |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +4.54% |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% |
| PHIL.MI | Philogen S.p.A. | $1.12B | Small cap | +2.12% |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% |
| CADL | Candel Therapeutics, Inc. | $1.04B | Small cap | +138.18% |
| GERN | Geron Corporation | $995.83M | Small cap | +9.15% |
| EUZ.DE | Eckert & Ziegler SE | $963.05M | Small cap | −23.06% |
| OLMA | Olema Pharmaceuticals, Inc. | $954.60M | Small cap | +95.17% |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +737.80% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +14.75% |
| AURA | Aura Biosciences, Inc. | $810.97M | Small cap | +19.94% |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −3.50% |
| MNPR | Monopar Therapeutics Inc. | $747.47M | Small cap | +264.30% |
| CTMX | CytomX Therapeutics, Inc. | $734.32M | Small cap | +68.50% |
| 4588.T | Oncolys BioPharma Inc. | $716.01M | Small cap | +526.71% |
| 0SZI.L | Corbus Pharmaceuticals Holdings, Inc. | $707.84M | Small cap | +5.13% |
| GUD.TO | Knight Therapeutics Inc. | $692.32M | Small cap | +49.08% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −16.33% |
| 0QAV.L | Nanobiotix S.A. | $671.98M | Small cap | +346.30% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $669.65M | Small cap | −27.91% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −21.16% |
| SGMT | Sagimet Biosciences Inc. | $639.61M | Small cap | +45.34% |
| CBIO | Crescent Biopharma, Inc. | $630.33M | Small cap | +15.65% |
| ARVN | Arvinas, Inc. | $610.71M | Small cap | +28.34% |
| DCTH | Delcath Systems, Inc. | $587.10M | Small cap | +55.37% |
| 0KCS.L | OPKO Health, Inc. | $578.38M | Small cap | +5.63% |
| PRLD | Prelude Therapeutics Incorporated | $524.86M | Small cap | +418.90% |
| CCCC | C4 Therapeutics, Inc. | $516.71M | Small cap | +66.01% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +78.67% |
| 0IL8.L | Kyntra Bio, Inc. | $512.46M | Small cap | −24.41% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $494.50M | Small cap | −91.09% |
| RLMD | Relmada Therapeutics, Inc. | $489.61M | Small cap | +635.58% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | $472.39M | Small cap | +1150.00% |
| PBYI | Puma Biotechnology, Inc. | $470.77M | Small cap | +86.77% |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −21.47% |
| CMPX | Compass Therapeutics, Inc. | $455.62M | Small cap | −16.23% |
| AVCT.L | Avacta Group Plc | $444.39M | Small cap | +32.31% |
| FENC | Fennec Pharmaceuticals Inc. | $410.64M | Small cap | +35.38% |
| FHTX | Foghorn Therapeutics Inc. | $406.79M | Small cap | +30.48% |
| PRTC.L | PureTech Health plc | $402.61M | Small cap | −11.34% |
| GALT | Galectin Therapeutics Inc. | $402.39M | Small cap | −0.25% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $392.65M | Small cap | +27.38% |
| AGEN | Agenus Inc. | $376.28M | Small cap | +90.43% |
| CATX | Perspective Therapeutics, Inc. | $375.56M | Small cap | −4.91% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $367.33M | Small cap | +113.19% |
| STRO | Sutro Biopharma, Inc. | $355.50M | Small cap | +155.24% |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.32% |
| IMRX | Immuneering Corporation | $338.37M | Small cap | −12.10% |
| BCYC | Bicycle Therapeutics plc | $306.47M | Small cap | −38.34% |
| RAC.AX | Racura Oncology Ltd | $303.46M | Small cap | +72.00% |
| WHWK | Whitehawk Therapeutics, Inc. | $278.20M | Small cap | +198.82% |
| ALXO | ALX Oncology Holdings Inc. | $276.55M | Small cap | +81.82% |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +100.70% |
| MGNX | MacroGenics, Inc. Common Stock | $265.63M | Small cap | +154.27% |
| TNG.PA | Transgene SA | $261.88M | Small cap | −16.98% |
| GLSI | Greenwich LifeSciences, Inc. | $258.04M | Small cap | +56.35% |
| 0IV3.L | Geron Corporation | $255.34M | Small cap | +8.41% |
| PYXS | Pyxis Oncology, Inc. | $255.23M | Small cap | +120.14% |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +1.34% |
| SPL.AX | Starpharma Holdings Limited | $252.95M | Small cap | +465.38% |
| ADAG | Adagene Inc. | $252.40M | Small cap | +62.55% |
| IDD.DE | Innate Pharma S.A. | $247.30M | Small cap | −2.52% |
| IPH.PA | Innate Pharma S.A. | $244.95M | Small cap | +1.84% |
| TARA | Protara Therapeutics, Inc. | $234.61M | Small cap | +30.16% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.75M | Small cap | +14.36% |
| NBP | NovaBridge Biosciences | $218.58M | Small cap | −59.96% |
| CHRS | Coherus Oncology, Inc. | $211.67M | Small cap | +17.09% |
| BINV.ST | BioInvent International AB (publ) | $169.15M | Small cap | −24.30% |
| MENS | Jyong Biotech Ltd. | $168.78M | Small cap | −95.26% |
| CUE | Cue Biopharma, Inc. | $168.39M | Small cap | +9.05% |
| MOLN | Molecular Partners AG | $164.30M | Small cap | +3.91% |
| KZIA | Kazia Therapeutics Limited | $157.58M | Small cap | +83.87% |
| OKUR | OnKure Therapeutics, Inc. | $155.52M | Small cap | +36.77% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +98.31% |
| INDP | Indaptus Therapeutics, Inc. | $145.90M | Small cap | −84.51% |
| 0IMT.L | Photocure ASA | $144.18M | Small cap | −12.59% |
| HPHA.DE | Heidelberg Pharma AG | $137.67M | Small cap | −44.40% |
| SCLP.L | Scancell Holdings plc | $137.37M | Small cap | −6.67% |
| ADCT | ADC Therapeutics SA | $132.77M | Small cap | −66.34% |
| HURA | TuHURA Biosciences, Inc. | $130.00M | Small cap | −30.85% |
| 0RU5.L | Oncoinvent ASA | $128.23M | Small cap | +5951.72% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | $127.21M | Small cap | +76.16% |
| LIXT | Nomad Power Solutions Inc | $125.36M | Small cap | +26.14% |
| BDTX | Black Diamond Therapeutics, Inc. | $123.81M | Small cap | −21.95% |
| ANIX | Anixa Biosciences, Inc. | $123.16M | Small cap | +22.00% |
| GNLX | Genelux Corporation | $123.07M | Small cap | −27.27% |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −18.72% |
| 0RDB.L | Oryzon Genomics S.A. | $121.50M | Small cap | +4.08% |
| RVU.WA | Ryvu Therapeutics S.A. | $117.79M | Small cap | −34.72% |
| 4889.T | Renascience Inc. | $117.04M | Small cap | −37.68% |
| FARN.L | Faron Pharmaceuticals Oy | $113.51M | Small cap | −80.71% |
| HBP.TO | Helix BioPharma Corp. | $109.87M | Small cap | +35.37% |
| ONCY | Oncolytics Biotech Inc. | $109.84M | Small cap | −12.99% |
| AMAN | Amanat Acquisition Corp | $103.43M | Small cap | +6.79% |
| JATT | JATT II Acquisition Corp. | $97.15M | Micro cap | +18.62% |
| 4575.T | CanBas Co., Ltd. | $96.08M | Micro cap | −40.51% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +63.91% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +4.58% |
| OSE.PA | OSE Immunotherapeutics SA | $88.77M | Micro cap | −47.82% |
| MAIA | MAIA Biotechnology, Inc. | $85.78M | Micro cap | −10.76% |
| CTOR | Citius Oncology, Inc. | $85.68M | Micro cap | −57.14% |
| 0QW5.L | Heidelberg Pharma AG | $84.14M | Micro cap | −45.58% |
| VRCA | Verrica Pharmaceuticals Inc. | $83.66M | Micro cap | −17.53% |
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −76.73% |
| POLB.L | Poolbeg Pharma PLC | $82.75M | Micro cap | +161.54% |
| 4888.T | Stella Pharma Corporation | $82.15M | Micro cap | −9.23% |
| CRDF | Cardiff Oncology, Inc. | $79.35M | Micro cap | −53.85% |
| 0QXX.L | Molecular Partners AG | $79.34M | Micro cap | +22.73% |
| ELTX | Elicio Therapeutics, Inc. | $79.11M | Micro cap | −72.71% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +318.64% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −24.66% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −23.49% |
| SAR.L | Sareum Holdings plc | $70.74M | Micro cap | +38.10% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −28.13% |
| PMVP | PMV Pharmaceuticals, Inc. | $69.76M | Micro cap | −8.10% |
| BOLD | Boundless Bio, Inc. | $67.33M | Micro cap | +160.18% |
| MAAT.PA | MaaT Pharma SA | $66.80M | Micro cap | −39.58% |
| RNXT | RenovoRx, Inc. | $64.08M | Micro cap | +58.13% |
| HRTX | Heron Therapeutics, Inc. | $61.34M | Micro cap | −76.59% |
| XLO | Xilio Therapeutics, Inc. | $59.75M | Micro cap | −7.35% |
| IMM.AX | Immutep Limited | $57.02M | Micro cap | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | $56.97M | Micro cap | −13.53% |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% |
| 4572.T | Carna Biosciences, Inc. | $55.69M | Micro cap | +83.26% |
| 0OCQ.L | Transgene SA | $55.45M | Micro cap | −18.38% |
| COIL.L | Coiled Therapeutics plc | $55.33M | Micro cap | −26.92% |
| 4564.T | OncoTherapy Science, Inc. | $53.87M | Micro cap | −25.00% |
| 0RAD.L | OSE Immunotherapeutics SA | $51.87M | Micro cap | −48.92% |
| TIL | Instil Bio, Inc. | $51.54M | Micro cap | −69.62% |
| 4597.T | Solasia Pharma K.K. | $51.47M | Micro cap | −23.68% |
| PTX.AX | Prescient Therapeutics Limited | $50.48M | Micro cap | +58.14% |
| CANTA.ST | Cantargia AB (publ) | $50.23M | Micro cap | −28.93% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −20.79% |
| BKHA | Black Hawk Acquisition Corporation | $49.39M | Micro cap | +8.09% |
| SVE.WA | Synthaverse S.A. | $47.84M | Micro cap | −37.70% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $46.25M | Micro cap | −33.75% |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.57% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $42.19M | Micro cap | −69.57% |
| MOC.WA | Molecure S.A. | $41.14M | Micro cap | −21.18% |
| CNTX | Context Therapeutics Inc. | $40.00M | Micro cap | −50.13% |
| 206A.T | PRISM BioLab Co.,LTD | $39.48M | Micro cap | −6.56% |
| SNT.AX | Syntara Limited | $36.57M | Micro cap | −1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | $34.51M | Micro cap | −58.56% |
| ATNM | Actinium Pharmaceuticals, Inc. | $33.88M | Micro cap | −39.66% |
| BCTX | BriaCell Therapeutics Corp. | $32.80M | Micro cap | −49.67% |
| KYNB | Kyntra Bio, Inc. | $32.80M | Micro cap | −23.80% |
| BCT.TO | BriaCell Therapeutics Corp. | $32.32M | Micro cap | −50.62% |
| 4582.T | SymBio Pharmaceuticals Limited | $31.73M | Micro cap | −58.28% |
| BYSI | BeyondSpring Inc. | $29.61M | Micro cap | −60.43% |
| MDNA.TO | Medicenna Therapeutics Corp. | $29.00M | Micro cap | −58.77% |
| EVAX | Evaxion A/S | $28.36M | Micro cap | +4.49% |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −52.30% |
| NNG.WA | NanoGroup S.A. | $27.54M | Micro cap | −14.09% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +13.33% |
| PSTV | Plus Therapeutics Inc | $26.64M | Micro cap | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $26.35M | Micro cap | −76.49% |
| CVM | CEL-SCI Corporation | $26.03M | Micro cap | −85.98% |
| IMU.AX | Imugene Limited | $25.70M | Micro cap | −73.33% |
| MRKR | Marker Therapeutics, Inc. | $25.34M | Micro cap | +20.63% |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −45.96% |
| BFRI | Biofrontera Inc. | $22.43M | Micro cap | +63.77% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.65% |
| ABVC | ABVC BioPharma, Inc. | $21.32M | Micro cap | −72.70% |
| ALLR | Allarity Therapeutics, Inc. | $21.16M | Micro cap | +41.34% |
| NOX.AX | Noxopharm Limited | $20.25M | Micro cap | −20.00% |
| DEX.ST | DexTech Medical AB | $20.14M | Micro cap | +20.93% |
| RADX | Radiopharm Theranostics Limited | $19.55M | Micro cap | −55.71% |
| TPST | Tempest Therapeutics, Inc. | $18.36M | Micro cap | −89.50% |
| B8FK.DE | Biofrontera AG | $17.95M | Micro cap | −4.55% |
| ABERA.ST | Abera Bioscience AB | $17.74M | Micro cap | −0.12% |
| 4882.T | Perseus Proteomics Inc. | $17.25M | Micro cap | −56.43% |
| RAD.AX | Radiopharm Theranostics Limited | $16.95M | Micro cap | −62.96% |
| CTXR | Citius Pharmaceuticals, Inc. | $16.57M | Micro cap | −52.09% |
| MDCX | Medicus Pharma Ltd. | $16.26M | Micro cap | −87.97% |
| INTS | Intensity Therapeutics, Inc. | $15.98M | Micro cap | −37.24% |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −31.23% |
| ACTI.ST | Active Biotech AB (publ) | $15.34M | Micro cap | −60.62% |
| AKTX | Akari Therapeutics, Plc | $14.54M | Micro cap | −77.77% |
| ALTME.PA | TME Pharma N.V. | $14.30M | Micro cap | +48.57% |
| PHIO | Phio Pharmaceuticals Corp. | $13.82M | Micro cap | −41.21% |
| GTBP | GT Biopharma, Inc. | $13.52M | Micro cap | −72.50% |
| BLRX | BioLineRx Ltd. | $12.45M | Micro cap | −25.97% |
| CRTX.L | CRISM Therapeutics Corporation | $12.43M | Micro cap | +9.52% |
| PDSB | PDS Biotechnology Corporation | $12.40M | Micro cap | −82.96% |
| MBRX | Moleculin Biotech, Inc. | $11.90M | Micro cap | −95.75% |
| TOVX | Theriva Biologics, Inc. | $10.90M | Micro cap | −45.33% |
| APRE | Aprea Therapeutics, Inc. | $10.14M | Micro cap | −40.63% |
| 0NWK.L | Valerio Therapeutics Société anonyme | $10.08M | Micro cap | +1214.52% |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −87.99% |
| PUR.WA | MultiQure S.A. | $9.74M | Micro cap | −53.66% |
| 4598.T | Delta-Fly Pharma, Inc. | $9.30M | Micro cap | −81.94% |
| XBIO | Xenetic Biosciences, Inc. | $8.93M | Micro cap | +33.57% |
| IMNN | Imunon, Inc. | $8.92M | Micro cap | −73.86% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −11.31% |
| AIM | AIM ImmunoTech Inc. | $7.73M | Micro cap | −89.97% |
| PAB.AX | Patrys Limited | $7.53M | Micro cap | −11.43% |
| CURX | Curanex Pharmaceuticals Inc | $7.45M | Micro cap | +18.16% |
| BOLT | Bolt Biotherapeutics, Inc. | $7.42M | Micro cap | −29.28% |
| CANF | Can-Fite BioPharma Ltd. | $7.11M | Micro cap | −74.46% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | $7.10M | Micro cap | −17.01% |
| CHOSA.ST | CHOSA Oncology AB | $7.04M | Micro cap | −12.00% |
| ITOC | iTonic Holdings Ltd. | $6.75M | Micro cap | −51.75% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +35.59% |
| NCNA | NuCana plc | $6.12M | Micro cap | −56.76% |
| PCSA | Processa Pharmaceuticals, Inc. | $6.09M | Micro cap | −60.36% |
| KAPA | Kairos Pharma, Ltd. | $5.88M | Micro cap | −79.82% |
| 0GP7.L | Medivir AB (publ) | $5.78M | Micro cap | +3.85% |
| NFX.L | Nuformix plc | $5.64M | Micro cap | +106.25% |
| PER.AX | PERCHERON FPO [PER] | $5.45M | Micro cap | −54.55% |
| BCAB | BioAtla, Inc. | $5.43M | Micro cap | −81.69% |
| HCWB | HCW Biologics Inc. | $4.77M | Micro cap | −53.15% |
| APVO | Aptevo Therapeutics Inc. | $4.43M | Micro cap | −92.81% |
| APS.TO | Aptose Biosciences Inc | $4.42M | Micro cap | +37.14% |
| OSRH | OSR Health, Inc. | $4.09M | Micro cap | −88.47% |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −3.64% |
| DBP-B.ST | Double Bond Pharmaceutical Int. | $3.69M | Micro cap | +9.33% |
| RDHL | RedHill Biopharma Ltd. | $3.68M | Micro cap | −55.83% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.39M | Micro cap | −16.03% |
| GOVX | GeoVax Labs, Inc. | $3.34M | Micro cap | −96.61% |
| ARTL | Artelo Biosciences, Inc. | $3.30M | Micro cap | −97.47% |
| IVX.AX | Invion Limited | $2.90M | Micro cap | −70.00% |
| VAL.L | ValiRx plc | $2.79M | Micro cap | −73.04% |
| NXTS | Nexentis Technologies Inc. | $2.69M | Micro cap | −96.64% |
| PPBT | Purple Biotech Ltd | $2.68M | Micro cap | −92.53% |
| RNAZ | TransCode Therapeutics, Inc. | $2.68M | Micro cap | −74.16% |
| PPCB | Propanc Biopharma, Inc. | $2.57M | Micro cap | −98.66% |
| 0RK9.L | Alligator Bioscience AB (publ) | $2.11M | Micro cap | −99.22% |
| SLXN | Silexion Therapeutics Corp | $2.04M | Micro cap | −94.88% |
| NX1.AX | Nexalis Therapeutics Limited | $1.99M | Micro cap | −50.00% |
| DCOY | Decoy Therapeutics Inc. | $1.95M | Micro cap | −95.58% |
| ATORX.ST | Alligator Bioscience AB (publ) | $1.88M | Micro cap | −99.30% |
| PTP.DE | Pentixapharm Holding AG N | $1.08M | Micro cap | +8.55% |
| BDRX | Biodexa Pharmaceuticals Plc | $1.07M | Micro cap | −96.20% |
| 0GQU.L | Active Biotech AB (publ) | $978.93K | Micro cap | +7801.59% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +260.94% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.